Computer Aided Detection Market by Applications (Breast Cancer, Lung Cancer, Colon/Rectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal Cancer), Breast CAD Imaging Modalities (Mammography, Magnetic Resonance Imaging, Ultrasound Imaging, Tomosynthesis, and Nuclear Imaging), Imaging Modalities (X-ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global computer aided detection market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising awareness regarding frequent health checkup due to growing number of health-conscious population and increasing prevalence of cancer globally.
Computer aided detection (CAD) is a clinically proven technology for diagnosing and detecting cancer, cardiovascular, and neurological diseases. This technology aids physicians in lowering the false negative rate, offering early diagnosing to detect cancer at early stage, lowering the chance of cancer and other illness death rates, and improving inter and intra reader variability. CAD systems are also widely utilized to assist physicians with a variety of tasks including providing a second opinion on diagnostic and detection outcomes and automatically detecting all non-calcified lesions suspected of malignancy on images.
Market Trends, Drivers, Restraints, and Opportunities
- Increased efficiency and effectiveness of CAD solutions due to development of advanced digital imaging technology is expected to boost the market growth.
- Wide prevalence of chronic illness and rising number of the global aging population are projected to fuel the market growth during the forecast period.
- Increasing demand for health insurance and government initiatives encouraging the development of advanced cancer screening systems are anticipated to drive the market expansion in the coming years.
- High cost of CAD solutions and requirement of skill technicians to handle CAD devices are likely to hamper the market growth during the forecast period.
- R&D investment from key players and gradual advancement of technology for computer aided detection with 3D imaging are projected to offer significant opportunities for the market expansion.
Scope of the Report
The report on the global computer aided detection market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Computer Aided Detection Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Applications (Breast Cancer, Lung Cancer, Colon/Rectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal Cancer), Breast CAD Imaging Modalities (Mammography, Magnetic Resonance Imaging, Ultrasound Imaging, Tomosynthesis, and Nuclear Imaging), Imaging Modalities (X-ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
EDDA Technology, Inc.; FUJIFILM Medical Systems; Hitachi High Technologies Corporation; Hologic Inc.; iCAD, Inc.; Vucomp; McKesson Corporation; Philips Healthcare; Siemens Healthcare; and Toshiba Medical Systems Corporation. |
Market Segment Insights
Breast cancer segment is expected to account for a key market share
Based on applications, the computer aided detection market is segmented into breast cancer, lung cancer, colon/rectal cancer, prostate cancer, liver cancer, bone cancer, and neurological/musculoskeletal cancer. The breast cancer segment is expected to account for a key share of the market during the forecast period owing to its increasing prevalence of breast cancer among women. Moreover, rising awareness to undergo cancer testing among pregnant women and their concerns for regular health checkups are key factors boosting the segment growth.
Mammography segment is projected to constitute a major share
In terms of breast CAD Imaging Modalities, the market is divided into mammography, magnetic resonance imaging, ultrasound imaging, tomosynthesis, and nuclear imaging. The mammography segment is projected to constitute a major share of the market during the forecast period due to rise in cancer cases, which is the leading cause of death and morbidity. Wide adoption of X-ray and other screening tests for detecting breast cancer among women are major driving factors for the segment growth since mammography represents a vital component for early diagnosis of breast cancer.
X-ray segment is expected to hold a large market share
Based on imaging modalities, the computer aided detection market is segmented into x-ray imaging, computed tomography, ultrasound imaging, magnetic resonance, and nuclear medicine imaging. The x-ray segment is expected to hold a large share of the market during the forecast period as it forms a core element for any imagining process that involve in the detection of all types of cancer. To overcome the limits of x-ray, several researches have been conducted, which present a major factor propelling the segment expansion.
North American is anticipated to dominate the market
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North American is anticipated to dominate the market CAGR during the forecast period owing to early acceptance of advanced technology in cancer diagnostics and treatment and increasing efforts in research to develop newer technology. Moreover, shifting trends towards workflow management functions for the diseases and conditions with form image analysis and pattern recognition algorithm are factors fueling the regional market expansion.
On the other hand, the market in Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to the fastest-growing market, development of cost-effective technologies, demand for medical tourism, and government initiatives and programs in the region.
Segments
Segments Covered in the ReportThe global computer aided detection market has been segmented on the basis of
Applications
- Breast Cancer
- Lung Cancer
- Colon/Rectal Cancer
- Prostate Cancer
- Liver Cancer
- Bone Cancer
- Neurological/Musculoskeletal Cancer
- Mammography
- Magnetic Resonance Imaging
- Ultrasound Imaging
- Tomosynthesis
- Nuclear Imaging
- X-ray Imaging
- Computed Tomography
- Ultrasound Imaging
- Magnetic Resonance
- Nuclear Medicine Imaging
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- EDDA Technology, Inc.
- FUJIFILM Medical Systems
- Hitachi High Technologies Corporation
- Hologic Inc.
- iCAD, Inc.
- Vucomp
- McKesson Corporation
- Philips Healthcare
- Siemens Healthcare
- Toshiba Medical Systems Corporation
Competitive Landscape
Key players competing in the global computer aided detection market are EDDA Technology, Inc.; FUJIFILM Medical Systems; Hitachi High Technologies Corporation; Hologic Inc.; iCAD, Inc.; Vucomp; McKesson Corporation; Philips Healthcare; Siemens Healthcare; and Toshiba Medical Systems Corporation.
Many of these key players have been widely adopting several business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Computer Aided Detection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Computer Aided Detection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Computer Aided Detection Market - Supply Chain
4.5. Global Computer Aided Detection Market Forecast
4.5.1. Computer Aided Detection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Computer Aided Detection Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Computer Aided Detection Market Absolute $ Opportunity
5. Global Computer Aided Detection Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Computer Aided Detection Market Size and Volume Forecast by Applications
5.3.1. Breast Cancer
5.3.2. Lung Cancer
5.3.3. Colon/Rectal Cancer
5.3.4. Prostate Cancer
5.3.5. Liver Cancer
5.3.6. Bone Cancer
5.3.7. Neurological/Musculoskeletal Cancer
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Computer Aided Detection Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Computer Aided Detection Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Computer Aided Detection Demand Share Forecast, 2019-2026
7. North America Computer Aided Detection Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Computer Aided Detection Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Computer Aided Detection Market Size and Volume Forecast by Applications
7.4.1. Breast Cancer
7.4.2. Lung Cancer
7.4.3. Colon/Rectal Cancer
7.4.4. Prostate Cancer
7.4.5. Liver Cancer
7.4.6. Bone Cancer
7.4.7. Neurological/Musculoskeletal Cancer
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Computer Aided Detection Demand Share Forecast, 2019-2026
8. Latin America Computer Aided Detection Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Computer Aided Detection Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Computer Aided Detection Market Size and Volume Forecast by Applications
8.4.1. Breast Cancer
8.4.2. Lung Cancer
8.4.3. Colon/Rectal Cancer
8.4.4. Prostate Cancer
8.4.5. Liver Cancer
8.4.6. Bone Cancer
8.4.7. Neurological/Musculoskeletal Cancer
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Computer Aided Detection Demand Share Forecast, 2019-2026
9. Europe Computer Aided Detection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Computer Aided Detection Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Computer Aided Detection Market Size and Volume Forecast by Applications
9.4.1. Breast Cancer
9.4.2. Lung Cancer
9.4.3. Colon/Rectal Cancer
9.4.4. Prostate Cancer
9.4.5. Liver Cancer
9.4.6. Bone Cancer
9.4.7. Neurological/Musculoskeletal Cancer
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Computer Aided Detection Demand Share Forecast, 2019-2026
10. Asia Pacific Computer Aided Detection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Computer Aided Detection Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Computer Aided Detection Market Size and Volume Forecast by Applications
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Colon/Rectal Cancer
10.4.4. Prostate Cancer
10.4.5. Liver Cancer
10.4.6. Bone Cancer
10.4.7. Neurological/Musculoskeletal Cancer
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Computer Aided Detection Demand Share Forecast, 2019-2026
11. Middle East & Africa Computer Aided Detection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Computer Aided Detection Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Computer Aided Detection Market Size and Volume Forecast by Applications
11.4.1. Breast Cancer
11.4.2. Lung Cancer
11.4.3. Colon/Rectal Cancer
11.4.4. Prostate Cancer
11.4.5. Liver Cancer
11.4.6. Bone Cancer
11.4.7. Neurological/Musculoskeletal Cancer
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Computer Aided Detection Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Computer Aided Detection Market: Market Share Analysis
12.2. Computer Aided Detection Distributors and Customers
12.3. Computer Aided Detection Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. EDDA Technology, Inc.
12.4.2. FUJIFILM Medical Systems
12.4.3. Hitachi High Technologies Corporation
12.4.4. Hologic Inc.
12.4.5. iCAD, Inc.
12.4.6. Vucomp
12.4.7. McKesson Corporation
12.4.8. Philips Healthcare</
2. Assumptions and Acronyms Used
3. Research Methodology
4. Computer Aided Detection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Computer Aided Detection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Computer Aided Detection Market - Supply Chain
4.5. Global Computer Aided Detection Market Forecast
4.5.1. Computer Aided Detection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Computer Aided Detection Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Computer Aided Detection Market Absolute $ Opportunity
5. Global Computer Aided Detection Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Computer Aided Detection Market Size and Volume Forecast by Applications
5.3.1. Breast Cancer
5.3.2. Lung Cancer
5.3.3. Colon/Rectal Cancer
5.3.4. Prostate Cancer
5.3.5. Liver Cancer
5.3.6. Bone Cancer
5.3.7. Neurological/Musculoskeletal Cancer
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Computer Aided Detection Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Computer Aided Detection Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Computer Aided Detection Demand Share Forecast, 2019-2026
7. North America Computer Aided Detection Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Computer Aided Detection Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Computer Aided Detection Market Size and Volume Forecast by Applications
7.4.1. Breast Cancer
7.4.2. Lung Cancer
7.4.3. Colon/Rectal Cancer
7.4.4. Prostate Cancer
7.4.5. Liver Cancer
7.4.6. Bone Cancer
7.4.7. Neurological/Musculoskeletal Cancer
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Computer Aided Detection Demand Share Forecast, 2019-2026
8. Latin America Computer Aided Detection Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Computer Aided Detection Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Computer Aided Detection Market Size and Volume Forecast by Applications
8.4.1. Breast Cancer
8.4.2. Lung Cancer
8.4.3. Colon/Rectal Cancer
8.4.4. Prostate Cancer
8.4.5. Liver Cancer
8.4.6. Bone Cancer
8.4.7. Neurological/Musculoskeletal Cancer
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Computer Aided Detection Demand Share Forecast, 2019-2026
9. Europe Computer Aided Detection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Computer Aided Detection Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Computer Aided Detection Market Size and Volume Forecast by Applications
9.4.1. Breast Cancer
9.4.2. Lung Cancer
9.4.3. Colon/Rectal Cancer
9.4.4. Prostate Cancer
9.4.5. Liver Cancer
9.4.6. Bone Cancer
9.4.7. Neurological/Musculoskeletal Cancer
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Computer Aided Detection Demand Share Forecast, 2019-2026
10. Asia Pacific Computer Aided Detection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Computer Aided Detection Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Computer Aided Detection Market Size and Volume Forecast by Applications
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Colon/Rectal Cancer
10.4.4. Prostate Cancer
10.4.5. Liver Cancer
10.4.6. Bone Cancer
10.4.7. Neurological/Musculoskeletal Cancer
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Computer Aided Detection Demand Share Forecast, 2019-2026
11. Middle East & Africa Computer Aided Detection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Computer Aided Detection Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Computer Aided Detection Market Size and Volume Forecast by Applications
11.4.1. Breast Cancer
11.4.2. Lung Cancer
11.4.3. Colon/Rectal Cancer
11.4.4. Prostate Cancer
11.4.5. Liver Cancer
11.4.6. Bone Cancer
11.4.7. Neurological/Musculoskeletal Cancer
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Computer Aided Detection Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Computer Aided Detection Market: Market Share Analysis
12.2. Computer Aided Detection Distributors and Customers
12.3. Computer Aided Detection Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. EDDA Technology, Inc.
12.4.2. FUJIFILM Medical Systems
12.4.3. Hitachi High Technologies Corporation
12.4.4. Hologic Inc.
12.4.5. iCAD, Inc.
12.4.6. Vucomp
12.4.7. McKesson Corporation
12.4.8. Philips Healthcare</
Segments Covered in the Report
The global computer aided detection market has been segmented on the basis of
Applications
The global computer aided detection market has been segmented on the basis of
Applications
- Breast Cancer
- Lung Cancer
- Colon/Rectal Cancer
- Prostate Cancer
- Liver Cancer
- Bone Cancer
- Neurological/Musculoskeletal Cancer
- Mammography
- Magnetic Resonance Imaging
- Ultrasound Imaging
- Tomosynthesis
- Nuclear Imaging
- X-ray Imaging
- Computed Tomography
- Ultrasound Imaging
- Magnetic Resonance
- Nuclear Medicine Imaging
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- EDDA Technology, Inc.
- FUJIFILM Medical Systems
- Hitachi High Technologies Corporation
- Hologic Inc.
- iCAD, Inc.
- Vucomp
- McKesson Corporation
- Philips Healthcare
- Siemens Healthcare
- Toshiba Medical Systems Corporation
Key players competing in the global computer aided detection market are EDDA Technology, Inc.; FUJIFILM Medical Systems; Hitachi High Technologies Corporation; Hologic Inc.; iCAD, Inc.; Vucomp; McKesson Corporation; Philips Healthcare; Siemens Healthcare; and Toshiba Medical Systems Corporation.
Many of these key players have been widely adopting several business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
Our Clients
Related Reports
Some other reports from this category!
